Clinical Trials Browser

Phase 2 × OTHER_GOV × Breast Cancer Recurrent × Clear all

NCT06458413 2024-06-13

Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer

Phase 2 Recruiting

Breast Cancer Recurrent